Märten Kuusk

Recent publications · Crossref

5 total works indexed

1. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

   · 2019 · cited 2,788x

2. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update

   · 2022 · cited 1,268x

3. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update

   · 2019 · cited 1,086x

4. Artificial intelligence for industry 4.0: Systematic review of applications, challenges, and opportunities

   · 2023 · cited 454x

5. Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial

   · 2017 · cited 435x

via Crossref · CC0